Exhibit 10.7

SETTLEMENT AND RELEASE

AGREEMENT

DENNIS BROVARONE

and

PURE BIOSCIENCE, INC.

EFFECTIVE DATE:

13 August 2013

--------------------------------------------------------------------------------

SETTLEMENT AND RELEASE AGREEMENT

I

PARTIES

THIS SETTLEMENT AND RELEASE AGREEMENT (the “Agreement”) is entered into
effective as of the 13th day of August, 2013 (the “Effective Date”), by and
between DENNIS BROVARONE, an individual residing in the State of California
(“Brovarone”); and, PURE BIOSCIENCE, INC., a Delaware corporation (“PURE”).
Brovarone and PURE are sometimes referred to collectively herein as the
“Parties”, and each individually as a “Party”.

II

RECITALS

A. Brovarone serves as a member of the Board of Directors of PURE (the “Board”).

B. Brovarone has previously provided legal services to PURE in his capacity as
an attorney.

C. As part of a reorganization and restructuring of PURE’s business, Brovarone’s
position as a member of the Board and as an attorney for PURE is hereby
terminated effective immediately by the mutual agreement of the Parties.

D. Subject to the terms and conditions of this Agreement, Brovarone is willing
to and hereby does provide assurances to PURE that he will not assert any claims
of any kind against PURE and specifically identified related parties, whether
arising out of (i) Brovarone’s status as a member of the Board; or, (ii) with
the exception of rights of the Parties created in this Agreement, any other
relationship or claim of right whatsoever arising out of or any manner or form
related to the relationship between the Parties.

E. This Agreement is to specifically encompass all of the claims and related
factual and legal circumstances noted above, including though not limited to all
rights, duties, and obligations arising under Brovarone’s rendering of legal
services to PURE (collectively referred to as the “Working Relationship”). As
such, it is the intent of the Parties that their respective rights and
obligations to each other from this day forward shall be determined exclusively
under the terms of this Agreement.

F. All Parties are desirous of settling all rights under the Working
Relationship and releasing each other from all future liability, except as
otherwise expressly provided herein to the contrary.

G. NOW, THEREFORE, in consideration of the promises and the mutual covenants
contained herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Parties, intending to be
legally bound, hereby agree as follows:

III

RELEASE AND PAYMENT OBLIGATIONS

3.1 Exchange. In consideration of (i) the execution of this Agreement; (ii) the
satisfaction of PURE’s obligations described below; (iii) the satisfaction of
Brovarone’s obligations described below; and, (iv) other good and valuable
consideration, the receipt and value of which is hereby confirmed, Brovarone on
the one hand, and PURE on the other hand, shall hereby fully, finally, and
forever settle and release each other from any and all claims, losses, fines,
penalties, damages, demands, judgments, debts, obligations, interests,
liabilities, causes of action, breaches of duty, costs, expenses, judgments and
injunctions of any nature whatsoever, whether known or unknown, from all
relationships between the Parties, specifically including, but not limited to,
those arising under or as a result of the Working Relationship (cumulatively
referred to as the “Released Claims”).

 

1

--------------------------------------------------------------------------------

3.2 Payment Obligations. Upon execution and delivery of this Agreement by
Brovarone and Brovarone’s termination of positions as envisioned hereunder, PURE
shall pay to Brovarone as a “Separation Payment” the sum of Ninety One Thousand
Three Hundred Thirty Two Dollars and Seventy Seven Cents ($91,332.77). Said
Separation Payment shall be payable as follows:

(a) No interest shall be accrued and no payments shall be made for the first
90-days after the Separation Date.

(b) After the first 90-days after the Separation Date two percent (2%) simple
interest per annum shall be applied to the Separation Payment.

(c) Payments of principal and interest shall be made in sixty (60) monthly
installments of One Thousand Six Hundred Dollars and Eighty Six Cents
($1,600.86) commencing one hundred twenty (120) days after the Separation Date,
and continuing thereafter on the same day of each month until the entire
Separation Payment and all accrued interest have been paid in full.

(d) PURE shall have the right to make payment on the Separation Payment, in
whole or in part, at any time and from time to time without penalty; however,
PURE shall provide Brovarone with thirty (30) days prior notice of prepayment
greater than the monthly installment.

(e) All payments of the Separation Payment, whether of principal or interest, or
both, shall be made by PURE to Brovarone in the form of check or wire transfer
in accordance with written instructions provided by Brovarone.

(f) Brovarone hereby acknowledges and agrees that the Separation Payment
represents payment in full of all salary, wages, compensation, unreimbursed
business expenses, pay, and any and all other amounts due and owing to Brovarone
as of the Separation Date. Brovarone further acknowledges and agrees that except
as otherwise expressly provided for herein, no additional compensation or
amounts of any kind are or will be due to Brovarone from PURE.

3.3 Conversion Right. Brovarone may at any time, in his sole and absolute
discretion upon ten (10) days written notice to PURE (the “Conversion Notice”),
convert the Separation Payment and accrued interest, in whole or in part (though
in no event for an amount less than Five Thousand Dollars), without any further
action by Brovarone (other than the Conversion Notice), into common stock of
PURE at a conversion price equal to the average closing price for PURE common
stock on the principal market on which PURE common stock is then listed or
quoted for the ten trading (10) days immediately preceding the date of the
Conversion Notice. Not later than five (5) business days after receipt of the
Conversion Notice PURE shall deliver, or cause to be delivered, to Brovarone the
number of shares of PURE common stock being acquired under the Conversion
Notice.

3.4 Complete Release and Hold Harmless. Brovarone, on behalf of himself, his
spouse, his heirs, personal representatives, successors, assigns and all others
claiming through or under him, and PURE, for itself and its successors and
assigns, hereby agree to release, discharge, and hold harmless each other and
their respective directors, officers, affiliates, and attorneys, and each of
their successors and assigns, from any and all known and unknown claims of every
nature and kind whatsoever which they now or hereafter may have with respect to
each other and/or the Released Claims, notwithstanding Section 1542 of the
California Civil Code, which provides that:

“A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR
SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE, AND WHICH IF
KNOWN BY HIM, MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR.”

 

2

--------------------------------------------------------------------------------

All rights under §1542 of the California Civil Code are hereto expressly, fully,
knowingly and intentionally forever waived and relinquished by the Parties. All
Parties hereby acknowledge that each understands the significance and
consequences of such specific waiver under §1542 of the California Civil Code,
and that each has had the opportunity to seek the advice of legal counsel of
their choosing.

3.5 Scope of Brovarone’s Release. Brovarone further expressly understands that
the rights being waived hereunder specifically include, but are not limited to,
any and all claims under (as any of the same may be amended from time to time)
Title VII of the Civil Rights Act of 1964; Sections 1981 and 1983 of the Civil
Rights Act of 1866; Equal Pay Act; Americans with Disabilities Act; Age
Discrimination in Employment Act; Brovarone Retirement Income Security Act; Fair
Labor Standards Act; Family and Medical Leave Act; WARN Act; the United States
and California Constitutions; California Fair Employment and Housing Act;
California Family Rights Act; California Labor Code; any applicable California
Industrial Welfare Commission Wage Order; with respect to the foregoing
constitutional and statutory references, any comparable constitution, statute or
regulation of any other state; all claims of discrimination or harassment on
account of race, sex, sexual orientation, national origin, religion, disability,
age, pregnancy, veteran’s status, or any other protected status under any
federal or state statute; any federal, state or local law enforcing express or
implied employment contracts or covenants of good faith and fair dealing; any
federal, state or local laws providing recourse for alleged wrongful discharge
or constructive discharge, termination in violation of public policy, tort,
physical or personal injury, emotional distress, fraud, negligent
misrepresentation, defamation, and any similar or related claim; together with
any claim under any other local, state or federal law or constitution governing
employment, discrimination or harassment in employment, or the payment of wages
or benefits, whether or not now known, suspected or claimed, which Brovarone
ever had, now has, or may claim to have as of the date of this Agreement. This
Agreement and the scope of the release by Brovarone hereunder expressly includes
any statutory claims, including, but not limited to, claims under the Age
Discrimination in Employment Act (the “ADEA”) and the Older Workers’ Benefit
Protection Act (“OWBPA”), except that this Agreement does not waive rights or
claims under the ADEA which may arise after the Effective Date of this
Agreement.

3.6 After Acquired Information. The Parties acknowledge that they may hereafter
discover information, facts, or circumstances different from or in addition to
those which they now know or believe to be true. Except as otherwise provided
herein to the contrary, this Agreement shall remain in full force and effect in
all respects notwithstanding such discovery, and in accordance with the
irrevocable waiver and relinquishment of provisions of California Civil Code
Section 1542 or otherwise, the Parties expressly accept and assume the risk of
such possible additions to or differences from those facts now known or believed
to be true.

3.7 Enforceability. The enforceability of this Agreement is conditioned upon
each respective Party satisfying its respective obligations hereunder.

3.8 Assignment of Released Claims. The Parties hereby covenant that none of the
Released Claims has been assigned to any other person, and that no other person
has any interest in any of the Released Claims. In the event any other person
asserts any interest with respect to the Released Claims, then the Party
breaching this covenant shall indemnify the Party against whom such claim is
asserted for any and all damages, costs, and fees.

3.9 Specific Exclusion. It is expressly understood that the release contained in
this Agreement does not encompass the promises and obligations of the Parties
under this Agreement. This Agreement also does not contemplate or include within
the release hereunder post-Effective Date intentionally willful, tortious, or
criminal acts of either Party, such acts being expressly excluded from this
Agreement.

3.10 No Admission of Liability. Notwithstanding the terms and conditions of this
Agreement, execution hereof shall in no manner or form constitute the admission
of liability or of responsibility by either Party in respect to the Working
Relationship or otherwise.

 

3

--------------------------------------------------------------------------------

IV

TERMINATION RELATED PROVISIONS

4.1 Termination By Mutual Agreement. The Parties hereby agree that Brovarone’s
termination of all position with PURE is by mutual agreement of the Parties and
is effective 13 August 2013 and that his last day as a member of the Board shall
be deemed to be the 13th day of August, 2013 (the “Separation Date”).

4.2 Termination of Positions By Mutual Agreement. As of the Separation Date and
as additional consideration hereunder, any and all positions held by Brovarone
in and with PURE have been terminated by the mutual agreement of the Parties.

4.3 Express Waiver of Any Other Amounts. Brovarone hereby acknowledges that he
is not entitled to receive, and will not claim, any damages, rights, benefits,
or compensation other than as expressly set forth in this Agreement.

4.4 Return of Materials. Upon execution of this Agreement and reasonable request
of PURE Brovarone shall deliver to PURE, at PURE’s expense, all equipment,
notebooks, documents, memoranda, reports, files, samples, books, correspondence,
lists, computer disks and data bases, computer programs and reports, computer
software, and all other written, graphic and computer generated or stored
records relating to the business of PURE which are or have been in the
possession or under the control of Brovarone.

4.5 Additional Information. As additional consideration in exchange for the
Separation Payment, Brovarone agrees to provide additional information
concerning PURE upon reasonable request of PURE for no additional charge from
the Separation Date up to and until eighteen (18) months thereafter (the
“Consulting Period”). It is the express intention of PURE that Brovarone
performs services during the Consulting Period as an independent contractor to
PURE. Nothing in this Agreement shall in any way be construed to constitute
Brovarone as an agent, employee, or representative of PURE. Without limiting the
generality of the foregoing, Brovarone is not authorized to bind PURE to any
liability or obligation or to represent that Brovarone has any such authority.
During the Consulting Period, upon the request of PURE, Brovarone shall be
reasonably available to consult with PURE for no more than 1-hour per week,
without carryovers.

V

CONFIDENTIALITY AND BUSINESS RELATED COVENANTS

5.1 Non-Disclosure of Business Information. Brovarone shall not at any time,
either directly or indirectly, use, divulge, disclose or communicate to any
person, firm, or corporation, in any manner whatsoever, any confidential
information concerning any matters affecting or relating to the business of
PURE, including, without limitation, the names, buying habits or practices of
any of its customers, its marketing methods and related data, the names of any
of its vendors or suppliers, costs of materials, the prices it obtains or has
obtained or at which it sells or has sold its products or services,
manufacturing and sales, costs, lists or other written records used in PURE’s
business, compensation paid to employees and other terms of employment, business
plans, financial projections and reports, business strategies, internal
operating procedures and other confidential business information from which the
PURE might derive an economic or competitive advantage, or any other
confidential information of, about or concerning the business of PURE, its
manner of operation, or other confidential data of any kind, nature, or
description, whether or not labeled “secret” or “confidential”. The Parties
hereby stipulate that as between them, the foregoing matters are important,
material, and confidential trade secrets and affect the successful conduct of
the PURE’s business and its goodwill, and that any breach of any term of this
paragraph is a material breach of this Agreement.

5.2 Trade Secrets. Brovarone shall not at any time, either directly or
indirectly, use, divulge, disclose or communicate to any person, firm, or
corporation, in any manner whatsoever, any of PURE’s trade secrets, including
without limitation, confidential information; customer lists; information
concerning current or any future

 

4

--------------------------------------------------------------------------------

and proposed work, services or products; the fact that any such work, services
or products are planned, under consideration, or in production, as well as any
description thereof, computer programs or computer software. Brovarone agrees
that these restrictions shall also apply to (i) trade secrets belonging to third
parties in the possession of PURE; and, (ii) trade secrets conceived,
originated, discovered, or developed by PURE during the term of his relationship
with PURE.

5.3 Competition Covenant. Brovarone hereby agrees that during and throughout the
forty-eight (48) months immediately following the Separation Date he shall not:

(a) Directly or indirectly, in an individual or representative capacity, own an
interest in, operate, join, control, finance (whether as a lender or investor),
share in the earnings of, participate in, engage in or be connected as an
officer, employee, agent, independent contractor, partner, shareholder, member,
consultant, employer, investor, or principal of any corporation, partnership,
proprietorship, firm, association, person, or any other entity engaged in any
aspect of the business of PURE, or which is otherwise in competition with PURE,
notwithstanding the location of said other business; and

(b) Permit his name to be used, directly or indirectly, by any person,
corporation, partnership or other business entity engaged in the business of
PURE.

5.4 Non-Solicitation of Employees. During and throughout the forty-eight
(48) months immediately following the Separation Date Brovarone shall not,
directly or indirectly, cause or induce, or attempt to cause or induce, any
employee of PURE to terminate his or her employment with PURE, as such
employment exists at any time following the Effective Date.

5.5 Non-Solicitation of Business. During and throughout the forty-eight
(48) months immediately following the Separation Date Brovarone shall not,
directly or indirectly, (i) solicit business from any customer of PURE, to the
extent such business relates to a product or service competitive with an PURE
product or service; or, (ii) otherwise attempt to induce any such customer of
PURE to cease doing business with, or to decrease the amount of business such
customer does with, PURE.

5.6 Mutual Non-Disparagement. Following the Separation Date: (i) Brovarone will
not make or cause to be made any statements or remarks (including, without
limitation, the repetition or distribution of disparaging, derogatory or
damaging rumors, allegations, negative reports or comments), whether written,
electronic or oral, that are directly or indirectly disparaging, derogatory or
damaging to PURE or any of its respective past, current or future affiliates,
officers, directors, shareholders, employees, consultants, advisors,
representatives, trustees, subsidiaries, divisions, parent companies, clients or
customers or their policies and procedures, business, practices or financial
condition; and, (ii) PURE will not make or cause to be made any statements or
remarks (including, without limitation, the repetition or distribution of
disparaging, derogatory or damaging rumors, allegations, negative reports or
comments), whether written, electronic or oral, that are directly or indirectly
disparaging, derogatory or damaging to Brovarone. However, the foregoing
restrictions shall not apply to any statements by Brovarone or by PURE that are
made truthfully in response to a subpoena or as otherwise required by applicable
law or other compulsory legal process, or those made in the context of a
confidential professional relationship such as between the Parties and legal
counsel, accountants and/or financial advisors.

VI

ADDITIONAL REPRESENTATIONS AND OBLIGATIONS

6.1 Consideration Period. This Agreement has been delivered to Brovarone on the
11th day of August, 2013. Pursuant to law, Brovarone has twenty-one (21) days to
consider this Agreement. Pursuant to Section 6.3, below, Brovarone has been
encouraged to seek legal counsel to consider and review this Agreement and based
on said review is waiving entitlement to said twenty-one day Consideration
Period.

 

5

--------------------------------------------------------------------------------

6.2 Revocation Period. Upon execution of this Agreement, Brovarone shall have
seven (7) days to revoke the Agreement. Any such revocation by Brovarone must be
in writing and delivered to PURE pursuant to the notice requirements of this
Agreement. If timely revoked by Brovarone, this Agreement will not be effective
or enforceable, and all Parties shall be immediately released of all obligations
hereunder, with no effect on any of the claims each Party may otherwise possess.

6.3 Independent Legal Counsel. The Parties to this Agreement warrant, represent,
and agree that in executing this Agreement, they do so with full knowledge of
the rights each may have with respect to the other Party, and that each has
received, or has had the opportunity to receive, independent legal advice as to
these rights. Each of the Parties has executed this Agreement with full
knowledge of these rights, and under no fraud, duress, or undue influence.

6.4 Waiver of Age Discrimination Claim. Brovarone understands that the release
contained in this Agreement had to meet certain requirements to constitute a
valid release of any claims under the Age Discrimination in Employment Act
(“ADEA”), and Brovarone hereby represents that all such requirements were in
fact satisfied. These requirements required the following, each of which has in
fact been satisfied: (i) execution of this Agreement by Brovarone has been
knowing and voluntary, and free from duress, coercion and mistake of fact;
(ii) this Agreement is in writing and is understandable; (iii) this Agreement
has waived current ADEA claims explicitly; (iv) this Agreement has not waived
future ADEA claims; (v) the release by Brovarone hereunder of ADEA claims has
been paid for with something to which Brovarone was not already entitled;
(vi) this Agreement has advised Brovarone to consult an attorney; (vii) this
Agreement has given Brovarone twenty-one (21) days to consider the ADEA release
contained in this Agreement; and, (viii) this Agreement has given Brovarone
seven (7) days within which to revoke the ADEA release contained in this
Agreement after execution.

6.5 Execution and Effect of Agreement.

6.5.1. By PURE. PURE hereby warrants and represents to Brovarone the following:

(a) It has the requisite power and authority to enter into and carry out the
terms and conditions of this Agreement, as well as all transactions contemplated
hereunder. All proceedings have been taken and all authorizations have been
secured which are necessary to authorize the execution, delivery, and
performance by PURE of this Agreement. This Agreement has been duly and validly
executed and delivered by PURE and constitutes the valid and binding obligations
of PURE, enforceable in accordance with the respective terms.

(b) The consummation by PURE of the transactions herein contemplated, including
the execution, delivery and consummation of this Agreement, will not violate any
judgment, law, order, writ, rule or regulation, or determination or decree of
any arbitrator, court, or other governmental agency or administrative body
(collectively, “Requirement of Law”) applicable or binding upon PURE.

6.5.2. By Brovarone. Brovarone hereby warrants and represents to PURE the
following:

(a) He has the requisite power and authority to enter into and carry out the
terms and conditions of this Agreement, as well as all transactions contemplated
hereunder. All proceedings have been taken and all authorizations have been
secured which are necessary to authorize the execution, delivery, and
performance by Brovarone of this Agreement. This Agreement has been duly and
validly executed and delivered by Brovarone and constitutes the valid and
binding obligations of Brovarone, enforceable in accordance with the respective
terms.

(b) The consummation by Brovarone of the transactions herein contemplated,
including the execution, delivery, and consummation of this Agreement, will not
violate any Requirement of Law applicable or binding upon Brovarone.

 

6

--------------------------------------------------------------------------------

6.6 Investment Representations. Brovarone is an “accredited investor”, as that
term is defined under Rule 501(a) of Regulation D under the Securities Act of
1933. Brovarone shall execute and deliver all documentation prepared and
reasonably requested by PURE in order to confirm Brovarone’s status as an
accredited investor.

6.7 No Cooperation. Brovarone will not act in any manner that might damage the
business of PURE. Brovarone will not counsel or assist any attorneys or their
clients in the presentation or prosecution of any disputes, differences,
grievances, claims, charges, or complaints by any third party against PURE
and/or any officer, director, employee, agent, representative, shareholder or
attorney of PURE, unless under a subpoena or other court order to do so or upon
the express written consent of PURE. Brovarone further agrees both to
immediately notify PURE upon receipt of any court order, subpoena, or any legal
discovery device that seeks or might require the disclosure or production of the
existence or terms of this Agreement, and to furnish, within two (2) business
days of its receipt, a copy of such subpoena or legal discovery device to PURE.

6.8 Expenses. Each Party shall pay the fees and expenses of such Party’s
advisers, counsel, accountants, and other experts, if any, and all other
expenses incurred by such Party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement, and shall hold the other
Party hereto harmless against, any liability, loss or expense (including,
without limitation, reasonable attorneys’ fees and out-of-pocket expenses)
arising in connection with any claim for such fees and expenses.

6.9 Tax Liability. Brovarone represents and warrants that neither PURE nor its
attorneys nor anyone affiliated with PURE has made any representations regarding
the taxability of the payments and issuance of stock hereunder and that
Brovarone has not relied upon any such representation in entering into this
Agreement. Brovarone further represents and warrants that he shall be solely
responsible for the payment of any and all federal, state and local taxes which
may become due, if any, as a result of the payments and issuance of stock
hereunder. Brovarone shall hold PURE harmless from and indemnify it for the
payment of any taxes (including interest) or penalties, and any costs or
attorneys’ fees related to such payment, if any, that may be asserted against it
by any government agency at any time as a result of the payments or issuance of
stock hereunder.

6.10 Death or Disability. In the event of Brovarone’s death or Complete
Disability, PURE will continue all commitments under this Agreement, including
but not limited to payments to Brovarone, his estate, successors, or assigns.
The term Complete Disability shall mean the inability of Brovarone to perform
his duties under this Agreement by reason of any incapacity, physical or mental,
based upon medical advice or an opinion provided by two licensed physicians
acceptable to PURE, determines to have incapacitated Brovarone from
satisfactorily performing his usual services for PURE under this Agreement.

6.11 Directors and Officers Insurance. For a period of five (5) years commencing
with the Separation Date, PURE shall continue to maintain directors and officers
insurance coverage on terms no less favorable than those in place on the
Separation Date. If for any reason PURE determines to discontinue such coverage
within said five year period, Brovarone shall be provided advanced written
notice of that event.

VII

INTENDED TAX RESULTS

7.1 Excise Tax. The Parties believe that the payments and issuance under this
Agreement do not constitute “excess parachute payments” under Section 280G of
the Internal Revenue Code of 1986, as amended (the “Code”), or any successor
provision. Notwithstanding such belief and intent, if any payment or benefit due
under this Agreement, together with all other payments and benefits (including,
without limitation, equity-based compensation awards) to which Brovarone is
entitled from PURE, would (if paid or provided) constitute an “excess parachute
payment”, the amounts otherwise payable and benefits otherwise due under this
Agreement will either (i) be delivered in full, or (ii) be limited to the
minimum extent necessary to ensure that no portion

 

7

--------------------------------------------------------------------------------

thereof will fail to be tax-deductible to PURE by reason of Section 280G of the
Code, whichever of the foregoing amounts, taking into account the applicable
federal, state or local income and employment taxes and the excise tax imposed
under Section 4999 of the Code, results in Brovarone’s receipt, on an after-tax
basis, of the greatest amount of benefits, notwithstanding that all or some
portion of such benefits may be subject to the excise tax imposed under
Section 4999 of the Code. In the event that the payments and/or benefits are to
be reduced pursuant to this Section 7.1, such payments and benefits shall be
reduced such that the reduction of compensation to be provided to Brovarone as a
result of this Section 7.1 is minimized. In applying this principle, the
reduction shall be made in a manner consistent with the requirements of
Section 409A of the Code and where two economically equivalent amounts are
subject to reduction but payable at different times, such amounts shall be
reduced on a pro rata basis but not below zero.

7.2 Compliance with Section 409A.

7.2.1. Intent. The intent of the Parties is that payments and benefits under
this Agreement comply with Section 409A of the Code and the regulations and
guidance promulgated thereunder (collectively “Section 409A”). Accordingly, to
the maximum extent permitted, this Agreement shall be interpreted to be in
compliance therewith. If Brovarone notifies PURE (with reasonable specificity as
to the reason therefor) that Brovarone believes that any provision of this
Agreement (or of any award of compensation, including equity compensation or
benefits) would cause Brovarone to incur any additional tax or interest under
Section 409A and PURE concurs with such belief or PURE (without any obligation
whatsoever to do so) independently makes such determination, PURE shall, after
consulting with Brovarone, reform such provision to attempt to comply with
Section 409A through good faith modifications to the minimum extent reasonably
appropriate to conform with Section 409A. To the extent that any provision
hereof is modified in order to comply with Section 409A, such modification shall
be made in good faith and shall, to the maximum extent reasonably possible,
maintain the original intent and economic benefit/burden to Brovarone and PURE
of the applicable provision without violating the provisions of Section 409A.

7.2.2. Specific Provisions. A termination of employment shall not be deemed to
have occurred for purposes of any provision of this Agreement providing for the
payment of any amounts or benefits upon or following a termination of employment
unless such termination is also a “separation from service” within the meaning
of Section 409A and, for purposes of any such provision of this Agreement,
references to a “termination,” “termination of employment” or like terms shall
mean “separation from service”. If Brovarone is deemed on the date of
termination to be a “specified employee” within the meaning of that term under
Section 409A(a)(2)(B) of the Code, then with regard to any payment or the
provision of any benefit that is specified as subject to this Section or that is
otherwise considered deferred compensation under Section 409A payable on account
of a “separation from service,” and that is not exempt from Section 409A as
involuntary separation pay or a short-term deferral (or otherwise), such payment
or benefit shall be made or provided at the date which is the earlier of (i) the
expiration of the six (6)-month period measured from the date of such
“separation from service” of Brovarone, and (ii) the date of Brovarone’s death
(the “Delay Period”). Upon the expiration of the Delay Period, all payments and
benefits delayed pursuant to this Section 7.2.2. (whether they would have
otherwise been payable in a single sum or in installments in the absence of such
delay) shall be paid or reimbursed to Brovarone in a lump sum without interest,
and any remaining payments and benefits due under this Agreement shall be paid
or provided in accordance with the normal payment dates specified for them
herein.

7.2.3. Reimbursement. With regard to any provision herein that provides for
reimbursement of costs and expenses or in-kind benefits, except as permitted by
Section 409A, (i) the right to reimbursement or in-kind benefits shall not be
subject to liquidation or exchange for another benefit, (ii) the amount of
expenses eligible for reimbursement, or in-kind benefits, provided during any
taxable year shall not affect the expenses eligible for reimbursement, or
in-kind benefits to be provided, in any other taxable year, provided that the
foregoing clause (ii) shall not be violated without regard to expenses
reimbursed under any arrangement covered by Section 105(b) of the Code solely
because such expenses are subject to a limit related to the period the

 

8

--------------------------------------------------------------------------------

arrangement is in effect and (iii) such payments shall be made on or before the
last day of Brovarone’s taxable year following the taxable year in which the
expense occurred.

7.2.4. Date of Payment. Whenever a payment under this Agreement specifies a
payment period with reference to a number of days, the actual date of payment
within the specified period shall be within the sole discretion of PURE.

VIII

ADDITIONAL PROVISIONS

8.1 Executed Counterparts. This Agreement may be executed in any number of
counterparts, all of which when taken together shall be considered one and the
same agreement, it being understood that all Parties need not sign the same
counterpart. In the event that any signature is delivered by fax or by e-mail
delivery of a “.pdf” format data file, such signature shall create a valid and
binding obligation of the Party executing (or on whose behalf such signature is
executed) with the same force and effect as if such facsimile or “.pdf”
signature page were an original thereof. Each of the Parties hereby expressly
forever waives any and all rights to raise the use of a fax machine or E-Mail to
deliver a signature, or the fact that any signature or agreement or instrument
was transmitted or communicated through the use of a fax machine or E-Mail, as a
defense to the formation of a contract.

8.2 Successors and Assigns. Except as expressly provided in this Agreement, each
and all of the covenants, terms, provisions, conditions and agreements herein
contained shall be binding upon and shall inure to the benefit of the successors
and assigns of the Parties hereto.

8.3 Article and Section Headings. The article and section headings used in this
Agreement are inserted for convenience and identification only and are not to be
used in any manner to interpret this Agreement.

8.4 Severability. Each and every provision of this Agreement is severable and
independent of any other term or provision of this Agreement. If any term or
provision hereof is held void or invalid for any reason by a court of competent
jurisdiction, such invalidity shall not affect the remainder of this Agreement.
Similarly, the obligations of the Parties shall remain in full force and effect
in the event any of the intended tax results hereunder shall be denied or
otherwise become unavailable.

8.5 Governing Law. This Agreement shall be governed by the laws of the State of
California, without giving effect to any choice or conflict of law provision or
rule (whether of the State of California or any other jurisdiction) that would
cause the application of the laws of any jurisdiction other than the State of
California. If any court action is necessary to interpret and or enforce the
terms and conditions of this Agreement, the Parties hereby agree that the
Superior Court of California, San Diego, shall be the sole jurisdiction and
venue for the bringing of such action.

8.6 Entire Agreement. This Agreement, and all references, documents, or
instruments referred to herein, contains the entire agreement and understanding
of the Parties hereto in respect to the subject matter contained herein. The
Parties have expressly not relied upon any promises, representations,
warranties, agreements, covenants, or undertakings, other than those expressly
set forth or referred to herein. This Agreement supersedes any and all prior
written or oral agreements, understandings, and negotiations between the Parties
with respect to the subject matter contained herein.

8.7 Additional Documentation. The Parties hereto agree to execute, acknowledge,
and cause to be filed and recorded, if necessary, any and all documents,
amendments, notices, and certificates which may be necessary or convenient under
the laws of the State of California.

 

9

--------------------------------------------------------------------------------

8.8 Attorney’s Fees. If any legal action (including arbitration) is necessary to
interpret and or enforce the terms and conditions of this Agreement, the
prevailing Party shall be entitled to costs and reasonable attorney’s fees.

8.9 Amendment. This Agreement may be amended or modified only by a writing
signed by all Parties.

8.10 Remedies.

8.10.1. Specific Performance. The Parties hereby declare that it is impossible
to measure in money the damages which will result from a failure to perform any
of the obligations under this Agreement. Therefore, each Party waives the claim
or defense that an adequate remedy at law exists in any action or proceeding
brought to enforce the provisions hereof.

8.10.2. Cumulative. The remedies of the Parties under this Agreement are
cumulative and shall not exclude any other remedies to which any person may be
lawfully entitled.

8.11 Waiver. No failure by any Party to insist on the strict performance of any
covenant, duty, agreement, or condition of this Agreement or to exercise any
right or remedy on a breach shall constitute a waiver of any such breach or of
any other covenant, duty, agreement, or condition.

8.12 Assignability. This Agreement is not assignable by either Party without the
expressed written consent of all Parties.

8.13 Notices.

8.13.1. Method and Delivery. All notices, requests and demands hereunder shall
be in writing and delivered by hand, by registered or certified mail, or by
recognized commercial over-night delivery service (such as Federal Express, UPS,
or DHL), and shall be deemed given (a) if by hand delivery, upon such delivery;
(b) if by mail, upon delivery of registered or certified mail, postage prepaid;
(c) if by recognized commercial over-night delivery service, upon such delivery.

8.13.2 Addresses for Notice.

If to PURE:

Attn: Chairman of the Board, Chief Executive Officer and Chief Financial Officer

1725 Gillespie Way

El Cajon, CA 92020

If to Brovarone:

35 Pinyon Pine Road

Littleton, CO 80127

8.14 Time. All Parties agree that time is of the essence as to this Agreement.

8.15 Provision Not Construed Against Party Drafting Agreement. This Agreement is
the result of negotiations by and between the Parties, and each Party has had
the opportunity to be represented by independent legal counsel of its choice.
This Agreement is the product of the work and efforts of all Parties, and shall
be deemed to have been drafted by all Parties. In the event of a dispute, no
Party hereto shall be entitled to claim that any provision should be construed
against any other Party by reason of the fact that it was drafted by one
particular Party.

 

10

--------------------------------------------------------------------------------

8.16 Incorporation of Exhibits and Schedules. The Exhibits and Schedules
identified in this Agreement are incorporated herein by reference and made a
part hereof as if set out in full herein.

8.17 Recitals. The facts recited in Article II, above, are hereby conclusively
presumed to be true as between and affecting the Parties.

8.18 Definitional Provisions. For purposes of this Agreement, (i) those words,
names, or terms which are specifically defined herein shall have the meaning
specifically ascribed to them; (ii) wherever from the context it appears
appropriate, each term stated either in the singular or plural shall include the
singular and plural; (iii) wherever from the context it appears appropriate, the
masculine, feminine, or neuter gender, shall each include the others; (iv) the
words “hereof”, “herein”, “hereunder”, and words of similar import, when used in
this Agreement, shall refer to this Agreement as a whole, and not to any
particular provision of this Agreement; (v) all references to designated
“Articles”, “Sections”, and to other subdivisions are to the designated
Articles, Sections, and other subdivisions of this Agreement as originally
executed; (vi) all references to “Dollars” or “$” shall be construed as being
United States dollars; (vii) the term “including” is not limiting and means
“including without limitation”; and, (viii) all references to all statutes,
statutory provisions, regulations, or similar administrative provisions shall be
construed as a reference to such statute, statutory provision, regulation, or
similar administrative provision as in force at the date of this Agreement and
as may be subsequently amended.

VIII

EXECUTION

IN WITNESS WHEREOF, this SETTLEMENT AND RELEASE AGREEMENT has been duly executed
by the Parties in San Diego, California, and shall be effective as of and on the
Effective Date set forth in Article I of this Agreement. Each of the undersigned
Parties hereby represents and warrants that it (i) has the requisite power and
authority to enter into and carry out the terms and conditions of this
Agreement, as well as all transactions contemplated hereunder; and, (ii) it is
duly authorized and empowered to execute and deliver this Agreement.

THE PARTIES HAVE CAREFULLY READ THIS ENTIRE AGREEMENT. ITS CONTENTS AND THE
RELEASE CONTAINED HEREIN HAVE BEEN FULLY EXPLAINED TO THEM BY THEIR ATTORNEYS,
OR THEY HAVE VOLUNTARILY ELECTED NOT TO SEEK THE ADVICE OF AN ATTORNEY. THE
PARTIES FULLY UNDERSTAND THE FINAL AND BINDING EFFECT OF THIS AGREEMENT. THE
ONLY PROMISES OR REPRESENTATIONS MADE TO EACH OF THE PARTIES ABOUT THIS
AGREEMENT, OR TO INDUCE THEM TO SIGN THIS AGREEMENT, ARE CONTAINED IN THIS
AGREEMENT. THE PARTIES ARE SIGNING THIS AGREEMENT KNOWINGLY AND VOLUNTARILY.

 

      BROVARONE:       PURE:      

PURE BIOSCIENCE, INC.,

a Delaware corporation

/s/ Dennis Brovarone       BY:   /s/ Dennis Atchley DENNIS BROVARONE       NAME:
  Dennis Atchley       TITLE:   Secretary DATED: 13 August 2013       DATED:
13 August 2013                                      

 

11